NCT05334472 A Survey to Evaluate Early Experience From Patient and Care Partner on Injection and Device for KESIMPTA® Indicated for Multiple Sclerosis Status COMPLETED Phase N/A
NCT05326711 Effects of Telerehabilitation-Based Motor Imagery Training on Pain in People With Multiple Sclerosis Status COMPLETED Phase NA
NCT05326048 Defining an Immunological Signature Related to Lesion Location in Multiple Sclerosis Status COMPLETED Phase N/A
NCT05320237 Immersive Virtual Reality for Upper Limb Rehabilitation in Multiple Sclerosis Status COMPLETED Phase NA
NCT05319093 Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients Status TERMINATED Phase N/A
NCT05301907 Survey Among Healthcare Professionals and MS Patients to Assess Their Understanding of RMP Materials Status COMPLETED Phase N/A
NCT05301335 Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study Status COMPLETED Phase NA
NCT05298670 Drug Repurposing Using Metformin for Improving the Therapeutic Outcome in Multiple Sclerosis Patients Status UNKNOWN Phase PHASE2
NCT05286242 Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient Patients Status COMPLETED Phase N/A
NCT05285904 Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients - an Observational Study Status COMPLETED Phase N/A
NCT05285891 Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis Status RECRUITING Phase PHASE4